BACKGROUND
Risk factors for rare gynecological cancers are largely unknown. Initial research has indicated that the metabolic syndrome (MetS) or individual components could play a role.
METHODS
The Metabolic syndrome and Cancer project cohort includes 288,834 women. During an average follow-up of 11